Quantum Biopharma (QNTM) Q1 2026 Earnings
QNTM·Reported May 7, 2026
Diluted EPS came in at $-3.06 (-117.0% YoY), missed the $-0.49 consensus by $2.57.
Diluted EPS
$-3.06missed by $2.57
Consensus: $-0.49
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q1 2026 Earnings FAQ
Common questions about Quantum Biopharma's Q1 2026 earnings report.
Quantum Biopharma (QNTM) reported Q1 2026 earnings on May 7, 2026.
Quantum Biopharma reported diluted EPS of $-3.06 for Q1 2026.
EPS missed the consensus estimate of $-0.49 by $2.57.
Compared to the same quarter a year prior, diluted EPS declined 117.0% from $-1.41.